Urologix Buy Hold or Sell Recommendation

ULGXDelisted Stock  USD 0.0001  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Urologix is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Urologix given historical horizon and risk tolerance towards Urologix. When Macroaxis issues a 'buy' or 'sell' recommendation for Urologix, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
In addition, we conduct extensive research on individual companies such as Urologix and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Urologix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Execute Urologix Buy or Sell Advice

The Urologix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Urologix. Macroaxis does not own or have any residual interests in Urologix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Urologix's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell UrologixBuy Urologix
Not Rated
For the selected time horizon Urologix has a Return On Asset of -0.0762, Profit Margin of (0.39) %, Operating Margin of (0.07) %, Current Valuation of 4.92 M, Shares Outstanding of 21.82 M and Number Of Shares Shorted of 41.23 K
We provide advice to complement the current expert consensus on Urologix. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Urologix is not overpriced, please validate all Urologix fundamentals, including its total debt, as well as the relationship between the earnings per share and retained earnings . As Urologix appears to be a penny stock we also recommend to double-check its revenue numbers.

Urologix Trading Alerts and Improvement Suggestions

Urologix is not yet fully synchronised with the market data
Urologix has some characteristics of a very speculative penny stock
Urologix has a very high chance of going through financial distress in the upcoming years
Urologix currently holds 4.59 M in liabilities. Urologix has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Urologix until it has trouble settling it off, either with new capital or with free cash flow. So, Urologix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Urologix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Urologix to invest in growth at high rates of return. When we think about Urologix's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 14.01 M. Net Loss for the year was (7.61 M) with profit before overhead, payroll, taxes, and interest of 5.9 M.
Urologix currently holds about 492 K in cash with (1.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Urologix current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Urologix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Urologix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Urologix Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Urologix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Urologix Buy or Sell Advice

When is the right time to buy or sell Urologix? Buying financial instruments such as Urologix Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Urologix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Blend Funds Thematic Idea Now

Large Blend Funds
Large Blend Funds Theme
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Urologix Pink Sheet

If you are still planning to invest in Urologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Urologix's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges